A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

NCT ID: NCT02620046

Last Updated: 2025-04-03

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

746 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-15

Study Completion Date

2024-06-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of the study is to check for long-term side effects of Vedolizumab Subcutaneous (also known as Vedolizumab SC) in people with ulcerative colitis (UC) and Crohn's disease (CD). Vedolizumab SC will be given as an injection just under the skin. This type of injection is called a subcutaneous injection or SC for short. Another aim of the study is to collect information on whether the participant's condition remains under control or improves during and after treatment with Vedolizumab SC.

Participants who previously took part in studies MLN0002SC-3027 or MLN0002SC-3031 will be invited to visit the study clinic. At this visit, the study doctor will check if each participant can take part in this study.

For those who can take part, participants will receive a subcutaneous injection of vedolizumab SC either once a week or once every 2 weeks. How often each participant receives vedolizumab SC will depend on their results from the previous study and on how active their condition is. Participants might be able to self-inject vedolizumab SC after being trained by the study doctors. During this study, the dose of vedolizumab SC might be increased for participants whose condition worsens.

Participants will continue treatment with vedolizumab SC until it is approved in their particular country, the participant decides to stop treatment, or the sponsor stops the study. If the sponsor stops the study before vedolizumab SC is approved in all countries, the sponsor will make sure all affected participants will have access to vedolizumab SC outside of the study.

After their final dose of vedolizumab SC, participants will visit the clinic 18 weeks later for a final check-up. Then, the clinic will telephone the participants 6 months after their final dose of vedolizumab SC to check if they have any health problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The drug being tested in this study is called vedolizumab subcutaneous (vedolizumab SC). Vedolizumab SC is being tested to assess its long-term safety and effectiveness in treating participants with UC or CD. This study will look at the long-term side effects and response/remission of UC and CD in participants who received vedolizumab SC in a prior vedolizumab SC study.

The study will enroll up to 692 patients. All participants enrolled in this study will have previously participated in the MLN0002SC-3027 or MLN0002SC-3031 study. Participants who completed the Maintenance Period (Week 52) in their previous study, or who did not achieve a clinical response at Week 6 but who did achieve a clinical response at Week 14 after having received a third vedolizumab IV infusion at Week 6 in their previous study, will receive open-label vedolizumab SC 108 mg, once every 2 weeks (Q2W). Participants who withdrew early from the Maintenance Period of their previous study due to disease worsening or need for rescue medications will receive open-label vedolizumab SC 108 mg, once every week (QW). Participants receiving SC 108 mg Q2W who experience treatment failure (disease worsening or need for rescue medications while in the current study will be dose escalated to vedolizumab SC 108 mg QW.

This multi-center trial will be conducted worldwide. Participation in this vedolizumab SC study will continue until vedolizumab SC becomes commercially available, the participant withdraws from the study, or the sponsor decides to close the study. Participants will make multiple visits to the clinic, plus a final visit 18 weeks after last dose of study drug for a follow-up assessment. Participants will also participate in a long-term safety follow-up, by phone, at 6 months after the last dose of study drug.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colitis, Ulcerative Crohn's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ulcerative Colitis: Vedolizumab 108 mg

Participants with ulcerative colitis (UC) who completed the Maintenance Phase in MLN0002SC-3027 (Week 52 assessment) or who did not achieve a clinical response at Week 6 in MLN0002SC-3027 but who did achieve a clinical response at Week 14 of the parent study after having received a third vedolizumab IV infusion at Week 6 in the parent study received vedolizumab SC 108 mg Q2W in this study whereas who withdrew early from the Maintenance Phase (at Week 14 onwards) in MLN0002SC-3027 due to disease worsening or need for rescue medications received vedolizumab SC 108 mg QW.

Group Type EXPERIMENTAL

Vedolizumab SC

Intervention Type DRUG

Vedolizumab SC 108 mg injection

Crohn's Disease: Vedolizumab 108 mg

Participants with Crohn's disease (CD) who completed the Maintenance Phase in MLN0002SC-3031 (Week 52 assessment) or who did not achieve a clinical response at Week 6 in MLN0002SC-3031 but who did achieve a clinical response at Week 14 of the parent study after having received a third vedolizumab IV infusion at Week 6 in the parent study received vedolizumab SC 108 mg Q2W in this study whereas who withdrew early from the Maintenance Phase (at Week 14 onwards) in MLN0002SC-3031 due to disease worsening or need for rescue medications received vedolizumab SC 108 mg QW.

Group Type EXPERIMENTAL

Vedolizumab SC

Intervention Type DRUG

Vedolizumab SC 108 mg injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vedolizumab SC

Vedolizumab SC 108 mg injection

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Prior participation in Study MLN0002SC-3027 or MLN0002SC-3031, and, in the opinion of the investigator, tolerated the study drug well. Early withdrawal from Study MLN0002SC-3027 or MLN0002SC-3031 must have been due to treatment failure during the Maintenance Period.

Exclusion Criteria

1. Surgical intervention for IBD during or after participation in Study MLN0002SC-3027 or MLN0002SC-3031, or at any time during this study.
2. Chronic or severe infection, or, any new, unstable, or uncontrolled cardiovascular, pulmonary, hepatic, renal, gastrointestinal, genitourinary, hematological, coagulation, immunological, endocrine/metabolic, neurologic, oncologic, or other medical disorder developed during or after participation in a prior vedolizumab study that, in the opinion of the investigator, would confound the study results or compromise participant safety.
3. Withdrawal from Study MLN0002SC-3027 or MLN0002SC-3031 due to a study-drug related adverse event (AE).
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Takeda

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director Clinical Science

Role: STUDY_DIRECTOR

Takeda

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arizona Arthritis & Rheumatology Research, PLLC

Phoenix, Arizona, United States

Site Status

Arkansas Primary Care Clinic, PA

Little Rock, Arkansas, United States

Site Status

Rocky Mountain Clinical Research, LLC

Wheat Ridge, Colorado, United States

Site Status

Medical Research Center of Connecticut, LLC

Hamden, Connecticut, United States

Site Status

Middlesex Gastroenterology Associates

Middletown, Connecticut, United States

Site Status

Nature Coast Clinical Research, LLC

Inverness, Florida, United States

Site Status

Florida Center for Gastroenterology

Largo, Florida, United States

Site Status

L & L Research Choices, Inc.

Miami, Florida, United States

Site Status

Gastroenterology Group of Naples

Naples, Florida, United States

Site Status

BRCR Medical Center, Inc.

Pembroke Pines, Florida, United States

Site Status

Shafran Gastroenterology Center

Winter Park, Florida, United States

Site Status

Florida Medical Clinic, P.A.

Zephyrhills, Florida, United States

Site Status

Atlanta Gastroenterology Associates

Atlanta, Georgia, United States

Site Status

Gastroenterology Associates of Central Georgia

Macon, Georgia, United States

Site Status

Atlanta Gastroenterology Specialists, PC

Suwanee, Georgia, United States

Site Status

Grand Teton Research Group, PLL

Idaho Falls, Idaho, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Carle Foundation Hospital

Urbana, Illinois, United States

Site Status

Cotton-O'Neil Clinical Research Center, Digestive Health

Topeka, Kansas, United States

Site Status

Tri-State Gastroenterology Associates

Crestview Hills, Kentucky, United States

Site Status

Research Concierge, LLC

Owensboro, Kentucky, United States

Site Status

Gastroenterology Associates, LLC

Baton Rouge, Louisiana, United States

Site Status

Lafayette General Medical Center

Lafayette, Louisiana, United States

Site Status

Louisiana Research Center, LLC

Shreveport, Louisiana, United States

Site Status

Metropolitan Gastroenterology Group, PC, Chevy Chase Clinical Research

Chevy Chase, Maryland, United States

Site Status

Clinical Research Institute of Michigan, LLC

Chesterfield, Michigan, United States

Site Status

Gastroenterology Associates of Western Michigan, P.L.C.

Wyoming, Michigan, United States

Site Status

Huron Gastroenterology Associates

Ypsilanti, Michigan, United States

Site Status

Mayo Clinic - Rochester

Rochester, Minnesota, United States

Site Status

Digestive Health Center PA

Ocean Springs, Mississippi, United States

Site Status

Ehrhardt Clinical Research, LLC

Belton, Missouri, United States

Site Status

AGA Clinical Research Associates, LLC

Egg Harbor, New Jersey, United States

Site Status

Long Island Clinical Research Associates

Great Neck, New York, United States

Site Status

Premier Medical Group of the Hudson Valley, PC

Poughkeepsie, New York, United States

Site Status

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Dayton Gastroenterology, Inc

Dayton, Ohio, United States

Site Status

Gastro-Enterology Research of Lima

Lima, Ohio, United States

Site Status

Options Health Research

Tulsa, Oklahoma, United States

Site Status

Main Line Gastroenterology Associates

Perkasie, Pennsylvania, United States

Site Status

Medical University of South Carolina (MUSC)

Charleston, South Carolina, United States

Site Status

Gastroenterology Center of the MidSouth PC

Germantown, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

San Antonio Gastroenterology

San Antonio, Texas, United States

Site Status

Tyler Research Institute, LLC

Tyler, Texas, United States

Site Status

Gastroenterology Associates of Tidewater

Chesapeake, Virginia, United States

Site Status

Virginia Mason Seattle Main Clinic

Seattle, Washington, United States

Site Status

Allegiance Research Specialists, LLC

Milwaukee, Wisconsin, United States

Site Status

Hospital Italiano

Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina

Site Status

Centro de Investigaciones Medicas Mar del Plata

Mar del Plata, Buenos Aires, Argentina

Site Status

Centro Medico Viamonte SRL

Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

Site Status

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Site Status

Nepean Hospital

Kingswood, New South Wales, Australia

Site Status

Mater Hospital Brisbane

South Brisbane, Queensland, Australia

Site Status

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Site Status

Tennyson Centre Day Hospital

Kurralta Park, South Australia, Australia

Site Status

Ballarat Base Hospital

Ballarat, Victoria, Australia

Site Status

Monash Medical Centre Clayton

Bentleigh East, Victoria, Australia

Site Status

St Vincent's Hospital Melbourne

Fitzroy, Victoria, Australia

Site Status

St Frances Xavier Cabrini Hospital

Malvern, Victoria, Australia

Site Status

Royal Melbourne Hospital

Melbourne, Victoria, Australia

Site Status

The Alfred Hospital

Melbourne, Victoria, Australia

Site Status

Fiona Stanley Hospital

Murdoch, Western Australia, Australia

Site Status

St John of God Subiaco Hospital

Subiaco, Western Australia, Australia

Site Status

Imeldaziekenhuis

Bonheiden, , Belgium

Site Status

AZ Sint-Lucas

Bruges, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

AZ Groeninge - Kennedylaan

Kortrijk, , Belgium

Site Status

ZNA Jan Palfijn

Merksem, , Belgium

Site Status

Clinique Saint-Pierre

Ottignies, , Belgium

Site Status

AZ Delta

Roeselare, , Belgium

Site Status

University Clinical Centre of the Republic of Srpska

Banja Luka, , Bosnia and Herzegovina

Site Status

University Clinical Hospital Mostar

Mostar, , Bosnia and Herzegovina

Site Status

Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda

Goiânia, Goiás, Brazil

Site Status

HUGG - Hospital Universitario Gaffree e Guinle

Rio de Janeiro, Rio Do Janeiro, Brazil

Site Status

HUCFF-UFRJ - Hospital Universitario Clementino Fraga Filho - Universidade Federal do Rio de Janeiro

Rio de Janeiro, Rio Do Janeiro, Brazil

Site Status

Hospital Sao Vicente de Paulo

Passo Fundo, Rio Grande do Sul, Brazil

Site Status

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu

Botucatu, São Paulo, Brazil

Site Status

Faculdade de Medicina do ABC

Santo André, São Paulo, Brazil

Site Status

Irmandade da Santa Casa da Misericordia de Santos

Santos, São Paulo, Brazil

Site Status

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto

São José do Rio Preto, São Paulo, Brazil

Site Status

"MHAT Avis - Medica" OOD

Pleven, , Bulgaria

Site Status

UMHAT 'Dr. Georgi Stranski', EAD

Pleven, , Bulgaria

Site Status

MHAT - Silistra AD

Silistra, , Bulgaria

Site Status

MC "Tsaritsa Yoanna' EOOD

Sliven, , Bulgaria

Site Status

MHAT "Hadzhi Dimitar", OOD

Sliven, , Bulgaria

Site Status

Second MHAT - Sofia AD

Sofia, , Bulgaria

Site Status

"City Clinic UMHAC" EOOD

Sofia, , Bulgaria

Site Status

Medical Center "Excelsior", OOD

Sofia, , Bulgaria

Site Status

UMHAT "Sv. Ivan Rilski", EAD

Sofia, , Bulgaria

Site Status

UMHAT 'Tsaritsa Yoanna - ISUL', EAD

Sofia, , Bulgaria

Site Status

Fourth MHAT - Sofia EAD

Sofia, , Bulgaria

Site Status

Military Medical Academy - MHAT - Sofia

Sofia, , Bulgaria

Site Status

UMHAT 'Sveta Anna' AD

Sofia, , Bulgaria

Site Status

Medical Center "Nov Rehabilitatsionen Tsentar", EOOD

Stara Zagora, , Bulgaria

Site Status

Zeidler Ledcor Centre - University of Alberta

Edmonton, Alberta, Canada

Site Status

PerCuro Clinical Research Ltd.

Victoria, British Columbia, Canada

Site Status

LHSC - University Hospital

London, Ontario, Canada

Site Status

LHSC - Victoria Hospital

London, Ontario, Canada

Site Status

Toronto Digestive Disease Associates, Inc.

Vaughan, Ontario, Canada

Site Status

Clinical Hospital Centre Osijek

Osijek, , Croatia

Site Status

Clinical Hospital Centre Rijeka

Rijeka, , Croatia

Site Status

Special Hospital Medico

Rijeka, , Croatia

Site Status

Clinical Hospital Dubrava

Zagreb, , Croatia

Site Status

University hospital centre Zagreb

Zagreb, , Croatia

Site Status

CCBR - Czech Brno, s.r.o..

Brno, , Czechia

Site Status

Hepato-Gastroenterologie HK s.r.o.

Hradec Králové, , Czechia

Site Status

A-SHINE s.r.o.

Pilsen, , Czechia

Site Status

CLINTRIAL s.r.o.

Prague, , Czechia

Site Status

CCBR Czech Prague, s.r.o.

Prague, , Czechia

Site Status

Axon Clinical s.r.o.

Prague, , Czechia

Site Status

Nemocnice Tabor a.s.

Tábor, , Czechia

Site Status

Odense Universitetshospital

Odense C, , Denmark

Site Status

Regionshospitalet Silkeborg

Silkeborg, , Denmark

Site Status

West Tallinn Central Hospital

Tallinn, , Estonia

Site Status

North Estonia Medical Centre Foundation

Tallinn, , Estonia

Site Status

Tartu University Hospital

Tartu, , Estonia

Site Status

LMU - Campus Grosshadern

Munich, Bavaria, Germany

Site Status

Klinikum der Johann Wolfgang Goethe-Universitaet

Frankfurt am Main, Hesse, Germany

Site Status

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany

Site Status

Universitaetsklinikum Koeln

Cologne, North Rhine-Westphalia, Germany

Site Status

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz

Mainz, Rhineland-Palatinate, Germany

Site Status

EUGASTRO GmbH

Leipzig, Saxony, Germany

Site Status

Universitaetsklinikum Magdeburg A.oe.R

Magdeburg, Saxony-Anhalt, Germany

Site Status

Universitaetsklinikum Schleswig-Holstein - Campus Kiel

Kiel, Schleswig-Holstein, Germany

Site Status

Universitaetsklinikum Schleswig-Holstein - Campus Luebeck

Lübeck, Schleswig-Holstein, Germany

Site Status

Charite - Campus Virchow-Klinikum

Berlin, , Germany

Site Status

DRK Kliniken Berlin Westend

Berlin, , Germany

Site Status

Krankenhaus Waldfriede e. V.

Berlin, , Germany

Site Status

Obudai Egeszsegugyi Centrum Kft.

Budapest, , Hungary

Site Status

Semmelweis Egyetem

Budapest, , Hungary

Site Status

Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak

Budapest, , Hungary

Site Status

Pannonia Maganorvosi Centrum

Budapest, , Hungary

Site Status

Markhot Ferenc Oktatokorhaz es Rendelointezet

Eger, , Hungary

Site Status

Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza

Gyula, , Hungary

Site Status

Pest Megyei Flor Ferenc Korhaz

Kistarcsa, , Hungary

Site Status

Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz

Miskolc, , Hungary

Site Status

Karolina Korhaz-Rendelointezet

Mosonmagyaróvár, , Hungary

Site Status

Pecsi Tudomanyegyetem

Pécs, , Hungary

Site Status

Tolna Megyei Balassa Janos Korhaz

Szekszárd, , Hungary

Site Status

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz

Székesfehérvár, , Hungary

Site Status

HaEmek Medical Center

Afula, , Israel

Site Status

Barzilai Medical Center

Ashkelon, , Israel

Site Status

Soroka University Medical Center

Beersheba, , Israel

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

Wolfson Medical Center

Holon, , Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Galilee Medical Center

Nahariya, , Israel

Site Status

Chaim Sheba Medical Center

Ramat Gan, , Israel

Site Status

Kaplan Medical Center

Rehovot, , Israel

Site Status

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

IRCCS Ospedale Casa Sollievo della Sofferenza

San Giovanni Rotondo, Foggia, Italy

Site Status

Istituto Clinico Humanitas

Rozzano, Milano, Italy

Site Status

I.R.C.C.S Policlinico San Donato

San Donato Milanese, Milano, Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi

Bologna, , Italy

Site Status

Azienda Ospedaliera Ospedale Cannizzaro

Catania, , Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico G. Martino

Messina, , Italy

Site Status

Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco)

Milan, , Italy

Site Status

A.O.U. Policlinico di Modena

Modena, , Italy

Site Status

Azienda Ospedaliera Universitaria "Federico II"

Napoli, , Italy

Site Status

Azienda Ospedaliera di Padova

Padua, , Italy

Site Status

Azienda Ospedaliera Vincenzo Cervello

Palermo, , Italy

Site Status

Azienda Ospedaliera San Camillo Forlanini

Roma, , Italy

Site Status

Policlinico Universitario Agostino Gemelli

Roma, , Italy

Site Status

Yokoyama IBD Clinic

Nagoya, Aichi-ken, Japan

Site Status

Toho University Sakura Medical Center

Sakura-shi, Chiba, Japan

Site Status

Ehime Prefectural Central Hospital

Matsuyama, Ehime, Japan

Site Status

Fukuoka University Chikushi Hospital

Chikushino-shi, Fukuoka, Japan

Site Status

Fukuoka University Hospital

Fukuoka, Fukuoka, Japan

Site Status

Kurume University Hospital

Kurume-shi, Fukuoka, Japan

Site Status

Hiroshima University Hospital

Hiroshima, Hiroshima, Japan

Site Status

Tokushukai Sapporo Tokushukai Hospital

Sapporo, Hokkaido, Japan

Site Status

Sapporo-Kosei General Hospital

Sapporo, Hokkaido, Japan

Site Status

Tokushukai Sapporo Higashi Tokushukai Hospital

Sapporo, Hokkaido, Japan

Site Status

Hyogo College of Medicine Hospital

Nishinomiya-shi, Hyōgo, Japan

Site Status

Iwate Medical University Hospital

Morioka, Iwate, Japan

Site Status

Kagawa Prefectural Central Hospital

Takamatsu, Kagawa-ken, Japan

Site Status

Gokeikai Ofuna Chuo Hospital

Kamakura-shi, Kanagawa, Japan

Site Status

Okayama University Hospital

Okayama, Okayama-ken, Japan

Site Status

Kinshukai Infusion Clinic

Osaka, Osaka, Japan

Site Status

Osaka City General Hospital

Osaka, Osaka, Japan

Site Status

Saga University Hospital

Saga, Saga-ken, Japan

Site Status

Shiga University of Medical Science Hospital

Ōtsu, Shiga, Japan

Site Status

Hamamatsu South Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Medical Hospital, Tokyo Medical and Dental University

Bunkyō City, Tokyo-To, Japan

Site Status

Jikei University Hospital

Minatoku, Tokyo-To, Japan

Site Status

Kitasato University Kitasato Institute Hospital

Minatoku, Tokyo-To, Japan

Site Status

Kyorin University Hospital

Mitaka-shi, Tokyo-To, Japan

Site Status

Keio University Hospital

Shinjuku-ku, Tokyo-To, Japan

Site Status

JCHO Tokyo Yamate Medical Center

Shinjuku-ku, Tokyo-To, Japan

Site Status

Wakayama Medical University Hospital

Wakayama, Wakayama, Japan

Site Status

Hospital of Lithuanian University of Health Sciences Kaunas Clinics

Kaunas, , Lithuania

Site Status

Klaipeda Republican Hospital, Public Institution

Klaipėda, , Lithuania

Site Status

Klaipeda University Hospital, Public Institution

Klaipėda, , Lithuania

Site Status

Vilnius University Hospital Santariskiu Clinics, Public Institution

Vilnius, , Lithuania

Site Status

Morales Vargas Centro de Investigacion, S.C.

León, Guanajuato, Mexico

Site Status

Centro de Investigacion Farmacologica del Bajio, S.C.

León, Guanajuato, Mexico

Site Status

iBiomed Guadalajara

Zapopan, Jalisco, Mexico

Site Status

Universidad Autonoma de Nuevo Leon, Hospital Universitario Dr. Jose Eleuterio Gonzalez

Monterrey, Nuevo León, Mexico

Site Status

Christus Muguerza Sur S.A. de C.V.

Monterrey, Nuevo León, Mexico

Site Status

Instituto de Investigaciones Aplicadas a la Neurociencia A.C.

Durango, , Mexico

Site Status

Sociedad de Metabolismo y Corazon S.C

Veracruz, , Mexico

Site Status

Academisch Medisch Centrum

Amsterdam, , Netherlands

Site Status

Albert Schweitzer Ziekenhuis

Dordrecht, , Netherlands

Site Status

Universitair Medisch Centrum Groningen (UMCG)

Groningen, , Netherlands

Site Status

Maastricht University Medical Center

Maastricht, , Netherlands

Site Status

Erasmus Medisch Centrum

Rotterdam, , Netherlands

Site Status

SP ZOZ Wojewodzki Szpital Zespolony im. J. Sniadeckiego

Bialystok, , Poland

Site Status

NZOZ Vitamed

Bydgoszcz, , Poland

Site Status

SP CSK im. prof. K. Gibinskiego SUM

Katowice, , Poland

Site Status

Gabinet Endoskopii Przewodu Pokarmowego

Krakow, , Poland

Site Status

SPZOZ Uniwersytecki Szpital Klin. nr 1 im.N.Barlickiego UM

Lodz, , Poland

Site Status

Santa Familia Centrum Badan, Profilaktyki i Leczenia

Lodz, , Poland

Site Status

GASTROMED Sp. z o.o.

Lublin, , Poland

Site Status

Twoja Przychodnia-Szczecinskie Centrum Medyczne

Szczecin, , Poland

Site Status

Centrum Zdrowia MDM

Warsaw, , Poland

Site Status

Centralny Szpital Kliniczny MSW w Warszawie

Warsaw, , Poland

Site Status

Centrum Onkologii-Instytut im. M. Sklodowskiej Curie

Warsaw, , Poland

Site Status

Nzoz Vivamed

Warsaw, , Poland

Site Status

LexMedica Osrodek Badan Klinicznych

Wroclaw, , Poland

Site Status

Ars-Medica S.C Rybak Maria, Rybak Zbigniew

Wroclaw, , Poland

Site Status

Spitalul Clinic Colentina

Bucharest, , Romania

Site Status

Institutul Clinic Fundeni

Bucharest, , Romania

Site Status

S.C Centrul de Gastroenterologie Dr. Goldis S.R.L

Timișoara, , Romania

Site Status

Kazan State Medical University

Kazan', , Russia

Site Status

TSBIH "Territorial Clinical Hospital"

Krasnoyarsk, , Russia

Site Status

FSBIH "Central Clinical Hospital of Russian Academy of Sciences"

Moscow, , Russia

Site Status

LLC "Novosibirsk GastroCenter"

Novosibirsk, , Russia

Site Status

SBEIHPE Novosibirsk State Medical University

Novosibirsk, , Russia

Site Status

BHI of Omsk region "Clinical Oncology Dispensary"

Omsk, , Russia

Site Status

SBEI HPE "Rostov State Medical University" of the MoH of the RF

Rostov-on-Don, , Russia

Site Status

SPb SBIH "City Hospital of Saint Martyr Elizaveta"

Saint Petersburg, , Russia

Site Status

LLC "RIAT SPb"

Saint Petersburg, , Russia

Site Status

SPb SBIH "City Hospital # 40 of Kurortnyi region"

Sestroretsk, , Russia

Site Status

Clinical Center of Serbia

Belgrade, , Serbia

Site Status

Clinical Helth Centre Zvezdara

Belgrade, , Serbia

Site Status

Military Medical Academy

Belgrade, , Serbia

Site Status

Clinical Center Bezanijska Kosa

Belgrade, , Serbia

Site Status

Clinical Center Zemun

Belgrade, , Serbia

Site Status

Clinical Center Kragujevac

Kragujevac, , Serbia

Site Status

Clinical Center Nis

Niš, , Serbia

Site Status

Clinical Center of Vojvodina

Novi Sad, , Serbia

Site Status

Fakultna nemocnica s poliklinikou F.D. Roosevelta

Banská Bystrica, , Slovakia

Site Status

Univerzitna nemocnica Bratislava, Nemocnica Ruzinov

Bratislava, , Slovakia

Site Status

Gastroped s.r.o.

Košice, , Slovakia

Site Status

KM Management spol. s r.o.

Nitra, , Slovakia

Site Status

Gastro I, s.r.o.

Prešov, , Slovakia

Site Status

Dr CCM Ziady Practice

Pretoria, Gauteng, South Africa

Site Status

Dr MJ Prins Practice

Cape Town, Western Cape, South Africa

Site Status

Dr JP Wright Practice

Cape Town, Western Cape, South Africa

Site Status

Kyungpook National University Hospital

Daegu, Gyeongsangbuk-do, South Korea

Site Status

Yeungnam University Hospital

Daegu, , South Korea

Site Status

Kyung Hee University Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Severance Hospital, Yonsei University

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, Spain

Site Status

Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, Madrid, Spain

Site Status

Hospital General Universitario de Alicante

Alicante, , Spain

Site Status

Hospital Universitari de Girona Dr Josep Trueta

Girona, , Spain

Site Status

Hospital Universitario Ramon y Cajal

Madrid, , Spain

Site Status

Complejo Hospitalario de Pontevedra

Pontevedra, , Spain

Site Status

Karolinska Universitetssjukhuset - Solna

Stockholm, , Sweden

Site Status

Danderyds Sjukhus

Stockholm, , Sweden

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Mackay Memorial Hospital

Taipei, , Taiwan

Site Status

Tri-Service General Hospital

Taipei, , Taiwan

Site Status

Ankara University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Gazi University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Acibadem Fulya Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Haydarpasa Numune Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Marmara University Pendik Research and Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Kocaeli Derince Training and Research Hospital

Kocaeli, , Turkey (Türkiye)

Site Status

Mersin University Medical Faculty

Mersin, , Turkey (Türkiye)

Site Status

RCNECRCH Dept of Surgery, SHEI Ukr BSMU

Chernivtsi, , Ukraine

Site Status

SI Institute of Gastroenterology of NAMSU Dept of Stomach & Duodenum Diseases, D&ThN SI DMA of MoHU

Dnipro, , Ukraine

Site Status

Regional CH Dep of Gastroenterology SHEI Ivano-Frankivsk NMU

Ivano-Frankivsk, , Ukraine

Site Status

CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC

Kharkiv, , Ukraine

Site Status

CI A.and O. Tropiny City Clinical Hospital

Kherson, , Ukraine

Site Status

CI of Kyiv RC Kyiv Regional Clinical Hospital

Kyiv, , Ukraine

Site Status

MI of Healthcare Kyiv RCH P.L. Shupyk NMA of PGE

Kyiv, , Ukraine

Site Status

Kyiv CCH #12 Dept of Therapy O.O.Bogomolets NMU

Kyiv, , Ukraine

Site Status

Communal City Clinical Hospital of Ambulance, Dept of Therapy #1 D.Halytskyi Lviv NMU

Lviv, , Ukraine

Site Status

CI Odesa Regional Clinical Hospital

Odesa, , Ukraine

Site Status

Ternopil University Hospital

Ternopil, , Ukraine

Site Status

Private Small Enterprise Medical Center Pulse

Vinnytsia, , Ukraine

Site Status

Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU

Vinnytsia, , Ukraine

Site Status

MCIC MC LLC Health Clinic

Vinnytsia, , Ukraine

Site Status

CI City Hospital #1

Zaporizhzhia, , Ukraine

Site Status

Royal Devon and Exeter Hospital (Wonford)

Exeter, Devon, United Kingdom

Site Status

Whipps Cross University Hospital

London, Greater London, United Kingdom

Site Status

Royal Free Hospital

London, Greater London, United Kingdom

Site Status

St George's Hospital

London, Greater London, United Kingdom

Site Status

Norfolk and Norwich University Hospital

Norwich, Norfolk, United Kingdom

Site Status

Royal Shrewsbury Hospital

Shrewsbury, Shropshire, United Kingdom

Site Status

University Hospital Coventry

Coventry, West Midlands, United Kingdom

Site Status

Royal Wolverhampton hospital

Wolverhampton, West Midlands, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Belgium Bosnia and Herzegovina Brazil Bulgaria Canada Croatia Czechia Denmark Estonia Germany Hungary Israel Italy Japan Lithuania Mexico Netherlands Poland Romania Russia Serbia Slovakia South Africa South Korea Spain Sweden Taiwan Turkey (Türkiye) Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Ungaro RC, Kadali H, Zhang W, Adsul S, Reinisch W. Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data. J Crohns Colitis. 2023 Dec 30;17(12):1949-1961. doi: 10.1093/ecco-jcc/jjad113.

Reference Type DERIVED
PMID: 37492976 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://clinicaltrials.takeda.com/study-detail/5f6b60274db2bf003ab498d5

To obtain more information on the study, click here/on this link

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1168-0921

Identifier Type: REGISTRY

Identifier Source: secondary_id

2015-000482-31

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

JapicCTI-163220

Identifier Type: REGISTRY

Identifier Source: secondary_id

MLN0002SC-3030CTIL

Identifier Type: REGISTRY

Identifier Source: secondary_id

16/LO/0110

Identifier Type: REGISTRY

Identifier Source: secondary_id

NL55765.056.16

Identifier Type: REGISTRY

Identifier Source: secondary_id

189751

Identifier Type: REGISTRY

Identifier Source: secondary_id

163300410A0052

Identifier Type: REGISTRY

Identifier Source: secondary_id

MOH_2017-01-05_000040

Identifier Type: OTHER

Identifier Source: secondary_id

MLN0002SC-3030

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.